LGR6 and ovarian carcinoma: In recent studies, LGR6 not only promotes the initiation and progression of cancers such as lung adenocarcinoma [28], luminal mammary tumor [27], and ovarian cancer [29] but also activates the phagocyte immunoresolvent function by binding to MaR1 [30].